Transplantation of pancreatic islets from other species to man has the
potential to cure diabetes, but whether such islet grafts will be sub
ject to damage due to natural antibody-mediated hyperacute rejection i
s unknown. We have examined the fate of islet xenografts in a recipien
t with direct relevance to man, the cynomolgus monkey. Rabbit islets w
ere prepared by an intraductal collagenase technique and incubated in
neat rabbit, human, or cynomolgus serum, with and without heat inactiv
ation, for up to 6 days. Islets were analyzed by flow cytometry for IG
G and IGM binding, and scored for viability by supravital staining. Fo
r in vivo studies, isolated islets were prepared from 4 New Zealand Wh
ite rabbits (15-34x10(3) islets 70-85% purity) and transplanted beneat
h the kidney capsule of normal cynomolgus monkeys after aggregation in
either a rabbit or monkey blood clot. The tissue was retrieved at var
ious times up to 4 days after transplantation and processed for light
and electron microscopy. The results showed that rabbit islets bind he
terophile antibody of both IGG and IGM subtypes. There was slow loss o
f islet viability in vitro over 3 days of culture in neat human or cyn
omolgus serum. Destruction of islets in vivo was more rapid with visib
le damage within 6 hr associated with neutrophil infiltration. Subsequ
ently, there was heavy mononuclear cell infiltration leading to total
destruction within 4 days. The results suggest that immediate mechanis
ms of graft rejection, possibly compliment and neutrophil mediated, re
present a major barrier to islet xenotransplantation in humans.